middle.news
InhalerX Secures $38.5M Funding Facility but Posts Negative Cash Flow
11:42am on Thursday 23rd of January, 2025 AEDT
•
Healthcare
Read Story
InhalerX Secures $38.5M Funding Facility but Posts Negative Cash Flow
11:42am on Thursday 23rd of January, 2025 AEDT
Key Points
Negative operating cash flow of $97,000 for the quarter
Secured $38.5 million funding facility from Clendon Biotech Capital
No drawdowns made on the new funding facility as of December 31, 2024
Cash and cash equivalents stood at $194,000 at quarter-end
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inhalerx (ASX:IRX)
OPEN ARTICLE